Sy, Eduardo C.
HRN: 21-46-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2022
CEFTAZIDIME 1GM (VIAL)
06/21/2022
06/27/2022
IV
1g
Q8
Infected Wound Left Foot
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes